TWD 23.9
(-1.65%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 777.76 Million TWD | -1.75% |
2022 | 791.63 Million TWD | 21.14% |
2021 | 653.49 Million TWD | 31.62% |
2020 | 496.51 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 777.76 Million TWD | 291.95% |
2024 Q2 | 193.76 Million TWD | -75.09% |
2023 Q3 | 198.43 Million TWD | 0.14% |
2023 FY | 777.76 Million TWD | -1.75% |
2023 Q4 | 198.43 Million TWD | 0.0% |
2023 Q2 | 198.14 Million TWD | 0.0% |
2023 Q1 | 198.14 Million TWD | 4.93% |
2022 FY | 791.63 Million TWD | 21.14% |
2022 Q4 | 188.84 Million TWD | 0.0% |
2021 FY | 653.49 Million TWD | 31.62% |
2020 FY | 496.51 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Lytone Enterprise, Inc. | 227.41 Million TWD | -242.002% |
Vetnostrum Animal Health Co., Ltd. | 356.76 Million TWD | -118.006% |